The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LTX-315, an oncolytic peptide, to convert immunogenically ‘cold' tumors to ‘hot' in patients with advanced or metastatic tumours: Results from an ongoing phase I study.
 
James F. Spicer
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Roche/Genentech
Speakers' Bureau - Lilly
 
Jean-Francois Baurain
Research Funding - Lytix Biopharma (Inst)
 
Ahmad Awada
Research Funding - Lytix Biopharma (Inst)
 
Rebecca Sophie Kristeleit
Honoraria - AstraZeneca; Clovis Oncology; Roche/Genentech
Consulting or Advisory Role - Cerulean Pharma; Clovis Oncology; Lytix Biopharma; Medivation; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; Valirx
 
Dag Erik Jossang
Research Funding - Lytix Biopharma (Inst)
 
Aurelien Marabelle
Consulting or Advisory Role - Lytix Biopharma
Research Funding - Lytix Biopharma (Inst)
 
Delphine Loirat
Research Funding - Lytix Biopharma (Inst)
 
Hedda Wold
Employment - Lytix Biopharma
Stock and Other Ownership Interests - Lytix Biopharma
 
Berit Nicolaisen
Employment - Lytix Biopharma
Stock and Other Ownership Interests - Lytix Biopharma
 
Oystein Rekdal
Employment - Lytix Biopharma
Stock and Other Ownership Interests - Lytix Biopharma
 
Wenche Marie Olsen
Employment - Lytix Biopharma
Stock and Other Ownership Interests - Lytix Biopharma
 
Andrew Saunders
Employment - Lytix Biopharma
Stock and Other Ownership Interests - Lytix Biopharma
 
Paal Brunsvig
Research Funding - Lytix Biopharma (Inst)